JONES FINANCIAL COMPANIES LLLP

Position in NBIX — Neurocrine Biosciences Inc

CIK 815917 DES PERES, MO

Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$5,645,247

+$2,595,336 QoQ

Shares Held

33,495

+44.7% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#200

of 768 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

JONES FINANCIAL COMPANIES LLLP holds $116,301,284 across 50 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HLN	Haleon plc	7,116,095	$66,393,166
2	ZTS	Zoetis Inc.	191,729	$13,777,645
3	TEVA	Teva Pharmaceutical Industries Ltd	332,250	$11,256,629
4	PBH	Prestige Consumer Healthcare Inc.	179,743	$8,496,451
5	NBIX	Neurocrine Biosciences Inc This page	33,495	$5,645,247
6	UTHR	UNITED THERAPEUTICS Corp	4,777	$2,588,321
7	VTRS	Viatris Inc	136,476	$2,167,238
8	AMRX	Amneal Pharmaceuticals, Inc.	110,479	$1,912,391

All Filings in NBIX

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,645,247	33,495	+44.7%	Shares	Sole	2026-08-14
2026-03-31	$3,049,911	23,151	+2723.3%	Shares	Sole	2026-05-15
2025-12-31	$116,300	820	+16.5%	Shares	Sole	2026-02-17
2025-09-30	$98,826	704	+17.3%	Shares	Sole	2025-11-04
2025-06-30	$75,413	600	+72.9%	Shares	Sole	2025-08-13
2025-03-31	$38,378	347	+86.6%	Shares	Sole	2025-05-28
2024-12-31	$25,389	186	+42.0%	Shares	Sole	2025-02-06
2024-09-30	$15,093	131	+445.8%	Shares	Sole	2024-11-12
2024-06-30	$3,304	24	+84.6%	Shares	Sole	2024-08-14
2022-06-30	$1,267	13	+116.7%	Shares	Sole	2022-08-08
2021-03-31	$583	6	—	Shares	Sole	2021-04-30
No filing history on record for this holder in this stock.